VA-103

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVA-103
Drug Alias NameVA-103
ClassificationBiologics
Mechanisms of ActionHaematopoiesis stimulants
TargetsUpdating
Therapy Area/IndicationsImmunologic Deficiency SyndromesBone Marrow Failure Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVacsyn SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVacsyn SA
Active IndicationsN/A
Inactive IndicationsImmunologic Deficiency SyndromesBone Marrow Failure Disorders

Other Information

ATC CodeN/A
Related LinksN/A